Why weight endotoxin testing so heavily when almost nobody publishes it?

Because a criterion should reflect what can go wrong, not what is convenient to score. It is the specific risk FDA recorded for this compound, purity testing does not detect it, and the same vendor publishes it on its June 2026 batches, so it is demonstrably achievable.

Does high purity make endotoxin testing unnecessary?

No. They measure different things. Purity is the proportion of the powder that is the intended sequence. Endotoxins are bacterial cell wall fragments that survive processes which kill bacteria and are invisible to a purity assay. A 99.32% pure powder can carry a pyrogen load that no HPLC trace would reveal.

Is the vendor you link the best source available?

It is the best we can evidence, on published documents, which is a narrower claim. It scores near full marks on its June 2026 batch and about 65 out of 100 on the February one, because the heaviest row depends on which certificate covers your vial. We have not tested competitors in a laboratory and we are not going to imply we have.

Would two independent laboratories be better than one?

Generally yes, and some products on this market carry certificates from two labs. This Selank lot has one, MZ Biolabs. A second independent document raises confidence in the result; it does not add a test that neither lab ran.

How much should price influence the decision?

Very little, which is why it carries 5%. The realistic spread between credible domestic sellers is a few dollars per vial. The spread between a documented batch and an undocumented one is the entire value of the purchase.

What is the single question to ask a supplier?

Whether they can supply a certificate covering the exact lot they will ship, including any endotoxin result. It tests batch traceability and testing scope at once, and the manner of the answer tells you as much as its content.

Best Selank Source: Judged on What the Lab Report Omits

Summary: The criteria and their weights are published before the result, so you can disagree with the method rather than the conclusion. No source on this market scores full marks, and the reason is the same one every time.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Best selank source is a question we can only answer usefully by publishing the method first, because a ranking with a hidden weighting is just an opinion with a table around it. Below is what we weigh, how heavily, and then where the source we link lands, including the criterion whose answer depends on which batch you are sent.

That source is here, so you can hold it against the method as you read.

Where readers actually buy it

Ascension Peptides — Selank

Research-grade Selank, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off

Selank · 10 mg$47.50$23.75$2.38/mgGet the 10 mg →

The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

Batch certificates from two independent labs
Free shipping over $250
Ships same day if ordered before 2pm CST

Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 21, 2026.

The category problem, stated once

Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, PubChem CID 11765600, formula C33H57N11O9, molecular weight 751.9 ^[4]. Its first four residues are tuftsin, a natural immune peptide, with a Pro-Gly-Pro tail added to slow enzymatic clearance. Russia registers it as an anxiolytic. Nothing in the West approves it for anything.

It has no relationship to the GLP-1 medications that make up most of this site. No incretin receptor activity, no gastric emptying effect, no weight-loss indication. Readers meet it in the same online spaces, which is a fact about those spaces.

The evidence position deserves a sentence of its own before any ranking, because it constrains how much a good supplier can be worth. There is a Russian clinical literature on Selank in anxiety disorders, including work published in Russian-language psychiatry journals ^[5]. We have not read those papers in the original and we are not going to characterise their findings, because Russian-language Selank trials are quoted second-hand across this market at strengths the abstracts do not support. What exists in English is largely animal work. Buying from the best available supplier does not change any of that. It changes only whether the powder is what the label says.

The weighting, published before the result

Criterion	Weight	Why it carries that weight
Testing scope, including whether endotoxin was assessed	35%	It is the one risk FDA named for this compound, and it is the criterion most of this market never addresses
Lot traceability	25%	A certificate that does not describe your batch describes nothing. This is binary and unforgiving
Analytical depth, purity and identity method	20%	HPLC with a visible chromatogram plus mass spec against 751.43 Da. A bare percentage is not a measurement
Provenance and logistics	10%	Domestic stock, a published dispatch cutoff, a readable refund policy, a return path that exists
Honest legal framing	5%	Research-use labelling and no human-use claims. A seller making clinical claims misunderstands its own position
Price	5%	It matters least. A cheap vial of the wrong material has no value at any price

Testing scope leads because of what FDA actually said. Its recorded position is that compounded drugs containing selank acetate "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and that the agency "lacks important information regarding any safety issues raised by selank acetate administered to humans" ^[1].

Unpack that and it becomes a testing specification rather than a warning label. Immunogenicity is an immune reaction to the material. Aggregation is peptide molecules clumping into structures that read as foreign. Peptide-related impurities are the truncated and modified sequences synthesis leaves behind. Purity by HPLC addresses the third. Nothing on a standard research certificate addresses pyrogen load, which needs a bacterial endotoxin or LAL assay of its own.

Price sits at 5% deliberately. In a market where the underlying compound has no approved product and no verifiable Western trial record, saving eight dollars is not a meaningful axis of comparison.

Best selank source: applying the weighting to the one we link

We link Ascension Peptides and earn a commission on purchases through the card above, disclosed there and in our disclaimer. Publishing the weighting first is the only way that disclosure means anything, so here is the scoring, row by row.

Lot traceability, 25%: passes. The certificate is tied to lot 29-01260229 with an analysis date of 2026-02-07, and it is issued by MZ Biolabs, a named laboratory at a checkable address in Tucson, Arizona, signed by an analytical chemist ^[2]. Not a site-wide graphic, not an undated PDF.

Analytical depth, 20%: passes well. Purity 99.32% by HPLC-UV, with the actual chromatogram and a peak list showing two detected peaks, the minor one at 0.68%. Identity by mass spectrometry, expected monoisotopic mass 751.43 Da against a measured 751.47 Da, with the recorded spectrum reproduced. The document also reports a measured quantity of 12.29 mg in a vial labelled 10 mg. Publishing an independent assay of fill weight is rare, and it is a number that could easily have gone the other way, which is what makes it worth crediting. It applies to that lot only and is not a promise about yours.

Provenance and logistics, 10%: passes. Domestic stock, same-day dispatch on orders before 2pm CST, free shipping from $250, quantity tiers of 3%, 5% and 10% at 3, 5 and 10 vials.

Honest legal framing, 5%: passes. Labelled for laboratory research only. No human-use claims, no dosing guidance on the listing.

Price, 5%: passes. $47.50 list, down from $60.00, and $23.75 with PEPTIDEDECK, which is $2.38 per milligram. Competitive without being implausible.

Testing scope, 35%: splits by batch, and the split is the finding. The certificate the product page links, February lot 29-01260229 from MZ Biolabs, carries no endotoxin test. No LAL, no pyrogen result, no sterility screen, no bioburden. We searched the document rather than assuming its absence. The June 2026 batch published on the same page, 29-05260628 certified 2 June by Kovera, does carry a bacterial endotoxin test by kinetic chromogenic LAL to USP Chapter 85, reported below 0.20 EU/mL against a 0.5 EU/mL limit, plus a rapid sterility screen and a heavy metals panel. The heaviest criterion is answered for one batch and unanswered for the other, so the only question that matters is which batch is in the vial you are sent.

That is close to full marks on the June batch and roughly 65 out of 100 on the February one, from the source we are paid to recommend. We would rather publish both numbers than quietly re-weight the table until it came out at 95 whichever document you land on.

Why the heaviest row splits in two, and the check it turns into

The obvious objection is that a 35% criterion almost nobody satisfies is a badly designed criterion. It is worth answering, because the answer is the most practically useful thing in this cluster.

Which testing you get here is a batch question rather than a product question. This vendor's February 2026 certificates report purity and identity only. Its June 2026 batches add a bacterial endotoxin test by kinetic chromogenic LAL to USP Chapter 85, reported below 0.20 EU/mL against a 0.5 EU/mL acceptance limit, alongside a rapid sterility screen and a heavy metals panel. The scope moved across the catalogue in June, on Selank and on its neighbouring Russian heptapeptide Semax alike, rather than for any one compound.

So the criterion is achievable, and this vendor has achieved it on its newer lots. It is a difference between testing rounds rather than an inherent limit of the compound or the supplier. The practical move is to open every certificate on the product page rather than only the one that happens to be a clickable link, because the fuller document is often the one sitting there as an image while the linked PDF is the older, thinner file.

That reframes the row. It is not an impossible standard used to make everyone look bad, it is a standard the same company already meets on its newer batches. Which makes "is there an endotoxin result for the lot you are shipping me" a reasonable question with a realistic chance of a real answer, rather than a rhetorical one.

The regulatory row that is not on the table, and why

Some rankings award points for regulatory standing. There are none available here, so we left the row off rather than inventing gradations.

Selank appears on no current FDA 503A bulks category list. Not Category 1, not Category 2, not Category 3; the lists updated May 14, 2026 do not contain it ^[3]. It appears instead on FDA's separate list of substances "nominated but withdrawn", which the agency introduces as substances "previously in category 2 of the interim policies" that "were withdrawn by the nominators" ^[1].

That is why competing pages calling it "Category 2" are working from a real but superseded position rather than making it up, and why calling it "banned from compounding" is wrong in the other direction. Current 503A Category 2 holds exactly six substances, and Selank is not among them ^[1]. No supplier can score better or worse on any of this, because it is a fact about the compound rather than about the seller.

How this method compares across the site

The weighting changes by compound, because the binding constraint changes. On NAD+, manufacturing grade dominates everything because FDA published a direct warning about food-grade material reaching syringes, which is why the NAD+ ranking leads on testing scope and settles ties on price. On BPC-157 the deciding factor is that suppliers vary enormously in what they will put in writing, covered in scoring BPC-157 suppliers on public facts. And on a compound with an actual trial record, the supplier question gets easier rather than harder, which is visible in why the retatrutide shortlist is short.

Selank sits at the difficult end: no approved product, no verifiable Western trial base, and a market-wide gap on the one test that would address the stated risk.

Questions about picking a source

Why weight endotoxin testing so heavily when almost nobody publishes it?: Because a criterion should reflect what can go wrong, not what is convenient to score. It is the specific risk FDA recorded for this compound, purity testing does not detect it, and the same vendor publishes it on its June 2026 batches, so it is demonstrably achievable.
Does high purity make endotoxin testing unnecessary?: No. They measure different things. Purity is the proportion of the powder that is the intended sequence. Endotoxins are bacterial cell wall fragments that survive processes which kill bacteria and are invisible to a purity assay. A 99.32% pure powder can carry a pyrogen load that no HPLC trace would reveal.
Is the vendor you link the best source available?: It is the best we can evidence, on published documents, which is a narrower claim. It scores near full marks on its June 2026 batch and about 65 out of 100 on the February one, because the heaviest row depends on which certificate covers your vial. We have not tested competitors in a laboratory and we are not going to imply we have.
Would two independent laboratories be better than one?: Generally yes, and some products on this market carry certificates from two labs. This Selank lot has one, MZ Biolabs. A second independent document raises confidence in the result; it does not add a test that neither lab ran.
How much should price influence the decision?: Very little, which is why it carries 5%. The realistic spread between credible domestic sellers is a few dollars per vial. The spread between a documented batch and an undocumented one is the entire value of the purchase.
What is the single question to ask a supplier?: Whether they can supply a certificate covering the exact lot they will ship, including any endotoxin result. It tests batch traceability and testing scope at once, and the manner of the answer tells you as much as its content.

Best selank source comes down to a market that documents identity and purity well and pyrogens rarely, and one vendor whose June 2026 batches show it can do better. Publish the weighting, apply it honestly, and the useful output is not a winner but a question worth asking before you pay.